KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $791.3 million.

  • West Pharmaceutical Services' Cash & Current Investments rose 6328.93% to $791.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $791.3 million, marking a year-over-year increase of 6328.93%. This contributed to the annual value of $791.3 million for FY2025, which is 6328.93% up from last year.
  • Latest data reveals that West Pharmaceutical Services reported Cash & Current Investments of $791.3 million as of Q4 2025, which was up 6328.93% from $628.5 million recorded in Q3 2025.
  • In the past 5 years, West Pharmaceutical Services' Cash & Current Investments registered a high of $898.6 million during Q3 2023, and its lowest value of $404.2 million during Q1 2025.
  • For the 5-year period, West Pharmaceutical Services' Cash & Current Investments averaged around $665.6 million, with its median value being $677.8 million (2021).
  • Its Cash & Current Investments has fluctuated over the past 5 years, first crashed by 4537.06% in 2024, then surged by 6328.93% in 2025.
  • Quarter analysis of 5 years shows West Pharmaceutical Services' Cash & Current Investments stood at $762.6 million in 2021, then grew by 17.27% to $894.3 million in 2022, then decreased by 4.52% to $853.9 million in 2023, then crashed by 43.25% to $484.6 million in 2024, then soared by 63.29% to $791.3 million in 2025.
  • Its last three reported values are $791.3 million in Q4 2025, $628.5 million for Q3 2025, and $509.7 million during Q2 2025.